-
公开(公告)号:US20180237817A1
公开(公告)日:2018-08-23
申请号:US15580121
申请日:2016-05-30
Applicant: CureVac AG
Inventor: Tilmann ROOS , Benyamin YAZDAN PANAH , Markus CONZELMANN , Andreas THESS , Dominik BUOB , Martin KUNZE , Veronika WAGNER
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N9/16 , C12N11/02 , C12N11/08 , C12Y201/01056 , C12Y201/01057 , C12Y207/0705 , C12Y301/03033
Abstract: The present invention relates to an immobilized capping enzyme, preferably an immobilized Vaccinia virus capping enzyme. Furthermore, the present invention relates to an immobilized cap-specific nucleoside 2′-O-methyltransferase, preferably an immobilized Vaccinia virus cap-specific nucleoside 2′-O-methyltransferase. Moreover, the present invention relates to a method for immobilizing said enzymes and to a method of using said enzymes for the addition of a 5′-cap structure to RNAs. Moreover, the present invention relates to an enzyme reactor for performing the capping reaction using said immobilized enzymes and the subsequent separation of the 5′-capped RNA product. In addition, the present invention relates to a kit comprising the capping enzyme and/or the cap-specific nucleoside 2′-O-methyltransferase.
-
公开(公告)号:US20230227881A1
公开(公告)日:2023-07-20
申请号:US18154437
申请日:2023-01-13
Applicant: CureVac SE
Inventor: Tilmann ROOS , Benyamin YAZDAN PANAH , Markus CONZELMANN , Andreas THESS , Dominik BUOB , Martin KUNZE , Veronika WAGNER
IPC: C12P19/34 , C12N9/10 , C12N9/16 , C12N9/12 , C12N11/02 , C12N11/087 , C12N11/098
CPC classification number: C12P19/34 , C12N9/1007 , C12Y201/01057 , C12Y201/01056 , C12Y301/03033 , C12N9/16 , C12Y207/0705 , C12N9/1241 , C12N11/02 , C12N11/087 , C12N11/098
Abstract: The present invention relates to an immobilized capping enzyme, preferably an immobilized Vaccinia virus capping enzyme. Furthermore, the present invention relates to an immobilized cap-specific nucleoside 2′-O-methyltransferase, preferably an immobilized Vaccinia virus cap-specific nucleoside 2′-O-methyltransferase. Moreover, the present invention relates to a method for immobilizing said enzymes and to a method of using said enzymes for the addition of a 5′-cap structure to RNAs. Moreover, the present invention relates to an enzyme reactor for performing the capping reaction using said immobilized enzymes and the subsequent separation of the 5′-capped RNA product. In addition, the present invention relates to a kit comprising the capping enzyme and/or the cap-specific nucleoside 2′-O-methyltransferase.
-
公开(公告)号:US20140363876A1
公开(公告)日:2014-12-11
申请号:US14471649
申请日:2014-08-28
Applicant: CELLSCRIPT, LLC
Inventor: Jerome Jendrisak , Ronald Meis , Gary Dahl
IPC: C12P19/34
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
Abstract: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
-
公开(公告)号:US20070281336A1
公开(公告)日:2007-12-06
申请号:US11787352
申请日:2007-04-16
Applicant: Jerome Jendrisak , Ronald Meis , Gary Dahl
Inventor: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
Abstract: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. The invention is used to obtain novel compositions of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA for a variety of research, therapeutic, and commercial applications. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, such as RNA synthesized in vitro or obtained from a biological source, including prokaryotic mRNA that is in a mixture with other prokaryotic and/or eukaryotic nucleic acids. The method for capturing modified-nucleotide-capped RNA also provides methods and kits for obtaining only type-specific or condition-specific modified-nucleotide-capped RNA by cap-dependent subtraction of that portion of the captured modified-nucleotide-capped RNA in cells of one type or condition that is the same as RNA in cells of another type or condition. The invention further provides methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
Abstract translation: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 本发明用于获得这种经修饰的核苷酸封端RNA分子的新组合物。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于体外生产具有修饰的帽核苷酸的5'上限的RNA,并且通过体外或体内翻译这些经修饰的核苷酸封端的RNA进行多种研究,体外或体内产生多肽 ,治疗和商业应用。 本发明还提供用于捕获或分离未包封的RNA的方法和试剂盒,其包含初级RNA转录物或具有5'-二磷酸的RNA,例如在体外合成或从生物来源获得的RNA,包括与其他原核生物混合的原核mRNA 和/或真核的核酸。 用于捕获修饰的核苷酸加帽的RNA的方法还提供用于仅通过Cap依赖性减去细胞中捕获的修饰核苷酸加帽的RNA的那部分获得仅特定类型或条件特异性修饰的核苷酸加帽的RNA的方法和试剂盒 与另一类型或病症细胞中的RNA相同的一种类型或病症。 本发明还提供了使用封端酶系统和修饰的帽核苷酸标记未封端RNA的方法和试剂盒,其包含具有可检测染料或酶部分的具有5'-二磷酸的初级RNA转录物或RNA。
-
公开(公告)号:US09115380B2
公开(公告)日:2015-08-25
申请号:US14666805
申请日:2015-03-24
Applicant: CELLSCRIPT, LLC
Inventor: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
Abstract: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
Abstract translation: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于通过体外或体内翻译这些经修饰的核苷酸加帽的RNA来体外生产具有修饰的帽核苷酸的5'-加帽的RNA,以及体外或体内产生多肽。 本发明还提供用于捕获或分离包含初级RNA转录物或具有5'-二磷酸的RNA的未封端RNA的方法和试剂盒,以及使用封端酶系统和修饰的帽核苷酸用于标记包含初级RNA转录物或RNA的未加帽RNA的方法和试剂盒 具有可检测的染料或酶部分的5'-二磷酸酯。
-
6.
公开(公告)号:US20150191760A1
公开(公告)日:2015-07-09
申请号:US14666805
申请日:2015-03-24
Applicant: CELLSCRIPT, LLC
Inventor: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
Abstract: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
Abstract translation: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于通过体外或体内翻译这些经修饰的核苷酸加帽的RNA来体外生产具有修饰的帽核苷酸的5'-加帽的RNA,以及体外或体内产生多肽。 本发明还提供用于捕获或分离包含初级RNA转录物或具有5'-二磷酸的RNA的未封端RNA的方法和试剂盒,以及使用封端酶系统和修饰的帽核苷酸用于标记包含初级RNA转录物或RNA的未加帽RNA的方法和试剂盒 具有可检测的染料或酶部分的5'-二磷酸酯。
-
公开(公告)号:US08846348B2
公开(公告)日:2014-09-30
申请号:US14185384
申请日:2014-02-20
Applicant: CellScript, LLC
Inventor: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
Abstract: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
Abstract translation: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于通过体外或体内翻译这些经修饰的核苷酸加帽的RNA来体外生产具有修饰的帽核苷酸的5'-加帽的RNA,以及体外或体内产生多肽。 本发明还提供用于捕获或分离包含初级RNA转录物或具有5'-二磷酸的RNA的未封端RNA的方法和试剂盒,以及使用封端酶系统和修饰的帽核苷酸用于标记包含初级RNA转录物或RNA的未加帽RNA的方法和试剂盒 具有可检测的染料或酶部分的5'-二磷酸酯。
-
公开(公告)号:US20230381296A1
公开(公告)日:2023-11-30
申请号:US18031570
申请日:2021-10-13
Inventor: Shinya OKAMURA , Akiho KASHIWABARA , Hirotaka EBINA
IPC: A61K39/215 , C12N7/00 , C12N9/10 , C12N9/16 , A61P31/14
CPC classification number: A61K39/215 , C12N7/00 , C12N9/1007 , C12Y201/01056 , C12Y201/01057 , C12N9/16 , C12Y301/03084 , A61P31/14 , C12N2770/20022 , C12N2770/20034 , C12N2770/20071 , A61K2039/5254
Abstract: Provided is a strain that is effective as an active ingredient of a vaccine against betacoronavirus. This SARS-CoV-2 includes non-structural protein(s) that has the following responsible mutation(s): a mutation in the amino acid residue corresponding to the L of position 445 of SEQ ID NO: 1 in NSP3; a mutation in the amino acid residues corresponding to the G of position 248 and the G of position 416 of SEQ ID NO: 2 in NSP14; and/or a mutation in the amino acid residue corresponding to the V of position 67 of SEQ ID NO: 3 in NSP16.
-
公开(公告)号:US20230210960A1
公开(公告)日:2023-07-06
申请号:US18000996
申请日:2021-06-03
Inventor: Young Sik LEE , Seung Jae LEE , Jae Sang HONG , Do Hwan LIM
IPC: A61K38/45 , C12N15/113 , C12N9/10 , C12N15/63
CPC classification number: A61K38/45 , C12N15/113 , C12N9/1007 , C12Y201/01057 , C12N15/63
Abstract: The present disclosure relates to a novel use of CMTR1 having the activity of enhancing the production and function of siRNA, and more particularly, to a composition for enhancing the production of siRNA including a cap1 2′-O-ribose methyltransferase (CMTR1) protein as an active ingredient, and a composition for enhancing the gene silencing activity by siRNA, and also to a method for producing siRNA for gene silencing in vitro. According to the present disclosure, the CMTR1 may enhance the production of siRNA for gene silencing and at the same time, ultimately enhance the production and function of siRNA without artificial chemical modification of siRNA by enhancing the formation of holo-RNA-induced silencing complex (RISC) that acts on silencing of a target gene in an RNAi mechanism. Therefore, the CMTR1 of the present disclosure can be usefully used in the development of pharmaceuticals using siRNA as a therapeutic agent.
-
公开(公告)号:US09005930B2
公开(公告)日:2015-04-14
申请号:US14471649
申请日:2014-08-28
Applicant: Cellscript, LLC
Inventor: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC classification number: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
Abstract: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
-
-
-
-
-
-
-
-
-